03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: RES02<br />

MultiStage: No<br />

DXCat Label: Asthma Specificity: A<br />

Etiology: Idiopathic; Immune<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Asymptomatic bronchial asthma History of bronchial asthma<br />

DX 49300, 49310, 49320, 49381-<br />

OR history of paroxysms of wheezing or bronchoconstriction that resolve<br />

with treatment<br />

49382, 49390;<br />

OR ≥ 15 % increase in forced expiratory volume in 1 second, FEV1,<br />

following two puffs of a beta-adrenergic agonist<br />

2.01 Mild intermittent bronchial asthma Stage 1.01<br />

AND diffuse bilateral expiratory or inspiratory wheezing<br />

AND peak expiratory flow rate or forced expiratory volume/min ≥ 80% predicted value<br />

[PEFR report]<br />

AND ≤ 2 days/week with asthma symptoms<br />

2.02 Mild persistent bronchial asthma Stage 1.01<br />

AND diffuse bilateral expiratory or inspiratory wheezing<br />

AND peak expiratory flow rate or forced expiratory volume/min ≥ 80% predicted value<br />

[PEFR report]<br />

AND 3-6 days/week with asthma symptoms<br />

2.03 Moderate persistent bronchial asthma Stage 1.01<br />

AND diffuse bilateral expiratory or inspiratory wheezing<br />

AND peak expiratory flow rate or forced expiratory volume/min ≤ 80% predicted value<br />

[PEFR report]<br />

AND peak expiratory flow rate or forced expiratory volume/min > 60% predicted value<br />

[PEFR report]<br />

OR daily asthma symptoms<br />

3.01 Severe persistent bronchial asthma Stage 1.01<br />

AND diffuse bilateral expiratory or inspiratory wheezing<br />

AND peak expiratory flow rate or forced expiratory volume/min ≤ 60% predicted value<br />

[PEFR report]<br />

OR continuous asthma symptoms<br />

3.02 Status asthmaticus or severe asthma Stage 2.01-3.01<br />

AND hypoxemia:<br />

AND peak expiratory flow rate or forced expiratory volume/min < 30% predicted value [PEFR<br />

report]<br />

OR PEFR < 100L/min [PEFR report]<br />

OR status asthmaticus<br />

3.03 with respiratory failure Stage 2.01-3.02<br />

AND respiratory failure:<br />

3.04 with shock Stage 1.01-3.03<br />

AND shock:<br />

DX 49302, 49312, 49322, 49392;<br />

NO;<br />

NO;<br />

NO;<br />

DX 49301, 49311, 49321, 49391;<br />

STAGE 1.01-3.02 + GROUP<br />

RESP_FAIL;<br />

STAGE 1.01-3.03 + (GROUP<br />

SHOCKC OR GROUP SHOCKN) ;<br />

Thursday, January 07, 2010 9:23:09 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!